Home › Funds › Millennium Management › CTXR
Millennium Management position in CTXR
CITIUS PHARMACEUTICALS INC · Health Care
Latest position (Q4 2024)32.32K sh
Reported value held$129.28K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 1.74M | $1.60M | New |
| Q3 2022 | 784.78K | $950.00K | Reduce |
| Q4 2022 | 551.13K | $435 | Reduce |
| Q1 2023 | 304.48K | $356 | Reduce |
| Q2 2023 | 62.67K | $75.21K | Reduce |
| Q2 2024 | 2.05M | $1.20M | New |
| Q3 2024 | 1.16M | $579.95K | Reduce |
| Q4 2024 | 32.32K | $129.28K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTXR
- Vanguard Group 199.26K sh · $154.82K · Q4 2025
- Geode Capital Management 215.54K sh · $130.30K · Q2 2026
- Citadel Advisors 124.91K sh · $75.51K · Q2 2026
- BlackRock Inc 69.85K sh · $42.22K · Q2 2026
- Northern Trust Corp 62.74K sh · $37.93K · Q2 2026
- UBS Group AG 26.34K sh · $15.93K · Q2 2026
- Two Sigma Investments 17.49K sh · $10.57K · Q2 2026
- Wells Fargo & Co 1.00K sh · $605 · Q2 2026
- JPMorgan Chase & Co 120 sh · $69 · Q2 2026
- Morgan Stanley 44 sh · $27 · Q2 2026